Catalent (CTLT) stock Forecast for 2022 – 2026
Last update: October 2, 2022 (07:43)Sector: Healthcare
The share price of Catalent, Inc. (CTLT) now
What analysts predict: $123.62
52-week high/low: $140.56 / $72.69
50/200 Day Moving Average: $99.31 / $103.99
This figure corresponds to the average price over the previous 50/200 days. For Catalent stocks, the 50-day moving average is the resistance level today.
For Catalent stocks, the 200-day moving average is the resistance level today.
Are you interested in Catalent, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Catalent stock price in 2022, 2023, 2024, 2025, 2026. How much will one Catalent share be worth in 2022 - 2026?
When should I take profit in Catalent stock? When should I record a loss on Catalent stock? What are analysts' forecasts for Catalent stock? What is the future of Catalent stock?
We forecast Catalent stock performance using neural networks based on historical data on Catalent stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Catalent stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Catalent shares. This happens once a day.
Historical and forecast chart of Catalent stock
The chart below shows the historical price of Catalent stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Catalent stock price can be found in the table below.
Long-term forecasts by years.
Catalent daily forecast for a month
Catalent Daily Price Targets
Catalent Stock Forecast 10-04-2022.
Pessimistic target level: 73.42
Optimistic target level: 74.99
Catalent Stock Forecast 10-05-2022.
Pessimistic target level: 73.22
Optimistic target level: 75.63
Catalent Stock Forecast 10-06-2022.
Pessimistic target level: 73.08
Optimistic target level: 75.31
Catalent Stock Forecast 10-07-2022.
Pessimistic target level: 72.79
Optimistic target level: 74.17
Catalent Stock Forecast 10-08-2022.
Pessimistic target level: 74.01
Optimistic target level: 75.71
Catalent Stock Forecast 10-09-2022.
Pessimistic target level: 73.96
Optimistic target level: 76.62
CTLT (CTLT) Monthly Stock Prediction for 2022
Catalent forecast for this year
Catalent Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $74.6817. Pessimistic: $73.16. Optimistic: $77.03
Catalent Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $75.2268. Pessimistic: $73.14. Optimistic: $78.96
Catalent Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $76.435. Pessimistic: $74.82. Optimistic: $79.00
Catalent (CTLT) Monthly Stock Prediction for 2023
Catalent (CTLT) Monthly Stock Prediction for 2024
Catalent (CTLT) Monthly Stock Prediction for 2025
Catalent (CTLT) Monthly Stock Prediction for 2026
Catalent information and performance
Catalent, Inc. Together with its subsidiaries, it provides delivery technologies and solutions for the development of drugs, biologics, consumer products and animal health products worldwide. It operates in four segments: gel capsules and oral technology, biologics, oral and specialty drugs, and medical services.
14 SCHOOLHOUSE ROAD, SOMERSET, NJ, US
Market Capitalization: 13 580 348 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 1 174 000 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 29.03
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 1.328
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0.051
Quarterly Revenue Growth YOY: 0.105
Trailing PE: 29.03
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 19.8
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 3.596
Enterprise Value (EV) /Revenue
EV To EBITDA: 15.7
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 179896000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.